Clinical heterogeneity of atypical fractures during prolonged use of bisphosphonates - Risk factors and bone turnover markers

被引：1
|
作者：
Piazzetta, Giovana [1 ]
Baracho, Filipe R. [2 ]
de Oliveira, Larissa [1 ]
Santos, Gustavo R. [1 ]
Kulak, Carolina A. M. [1 ,3 ]
Borba, Victoria Z. C. [1 ,3 ]
机构：
[1] UFPR, Hosp Clin, Dept Clin Med, Curitiba, PR, Brazil
[2] UFPR, Hosp Clin, Dept Ortopedia & Traumatol, Curitiba, PR, Brazil
[3] UFPR, Hosp Clin, SEMPR, Serv Endocrinol, Curitiba, PR, Brazil
来源：
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA | 2014年 / 58卷 / 08期
关键词：
FEMORAL FRACTURES; POSTMENOPAUSAL WOMEN; BIOCHEMICAL MARKERS; STRONTIUM RANELATE; OSTEOPOROSIS; MICROARCHITECTURE; ALENDRONATE; STRENGTH; THERAPY;
D O I：
10.1590/0004-2730000003229
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：855 / 861
页数：7
相关论文
共 37 条
  • [1] Atypical Femoral Fractures during Prolonged Use of Bisphosphonates: Short-Term Responses to Strontium Ranelate and Teriparatide
    Carvalho, N. N. C.
    Voss, L. A.
    Almeida, M. O. P.
    Salgado, C. L.
    Bandeira, F.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (09): : 2675 - 2680
  • [2] Use of bone turnover markers in clinical practice
    Biver, Emmanuel
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2012, 19 (06) : 468 - 473
  • [3] Bone turnover markers and the factors associated with atypical femur fractures among Japanese patients
    Iizuka, Yoichi
    Iizuka, Haku
    Kaneko, Tetsuya
    Mieda, Tokue
    Takechi, Rumi
    Suzuki, Hideki
    Sorimachi, Yasunori
    Suto, Takahito
    Tachibana, Masahiro
    Yoneyama, Tomotaka
    Omodaka, Takuya
    Hashimoto, Shogo
    Hamano, Noritaka
    Sakane, Hideo
    Shimoyama, Daisuke
    Kohama, Isaku
    Ohshima, Atsufumi
    Nozaki, Tatsuya
    Kamiyama, Masataka
    Moteki, Tomohiko
    Ohshima, Asuka
    Takamine, Shuhei
    Honda, Akira
    Ueno, Akira
    Tajika, Tsuyoshi
    Okamura, Koichi
    Warita, Toshiro
    Yonemoto, Yukio
    Shitara, Hitoshi
    Ohsawa, Takashi
    Takagishi, Kenji
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2016, 47 (11): : 2484 - 2489
  • [4] The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis
    Vasikaran, Samuel D.
    Chubb, S. A. Paul
    ENDOCRINE, 2016, 52 (02) : 222 - 225
  • [5] Biochemical markers of bone turnover and their clinical use
    Meier, Ch
    OSTEOLOGIE, 2009, 18 (01) : 10 - 15
  • [6] Capture the fracture - Use of bone turnover markers in clinical practice
    Vuksanovic, Miljanka
    Beljic-Zivkovic, Teodora
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2016, 144 (7-8) : 450 - 455
  • [7] Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis
    Naylor, K. E.
    Mccloskey, E., V
    Jacques, R. M.
    Peel, N. F. A.
    Paggiosi, M. A.
    Gossiel, F.
    Walsh, J. S.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (04) : 917 - 922
  • [8] Are secondary effects of bisphosphonates on the vascular system of bone contributing to increased risk for atypical femoral fractures in osteoporosis?
    Hart, David A.
    BIOESSAYS, 2023, 45 (04)
  • [9] Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis
    K.E. Naylor
    E.V. McCloskey
    R.M. Jacques
    N.F.A. Peel
    M.A. Paggiosi
    F. Gossiel
    J.S. Walsh
    R. Eastell
    Osteoporosis International, 2019, 30 : 917 - 922
  • [10] The role of bone turnover markers and risk factors in the assessment of osteoporosis and fracture risk
    Clowes, JA
    Eastell, R
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 14 (02) : 213 - 232
1234